Skip to main content
PLOS One logoLink to PLOS One
. 2026 Feb 4;21(2):e0340957. doi: 10.1371/journal.pone.0340957

Quantitative and temporal analysis of autophagy: Differential Response to amino acid and glucose starvation

Katie R Martin 1,#, Stephanie L Celano 1,#, Jessica D Guillaume 1, Ryan D Sheldon 2, Russell G Jones 3, Jeffrey P MacKeigan 1,*
Editor: Mohamed Abdelkarim4
PMCID: PMC12872001  PMID: 41637269

Abstract

Autophagy is a highly conserved, intracellular recycling process by which cytoplasmic contents are degraded in the lysosome. This process occurs at a low level constitutively; however, it is induced robustly in response to stressors, in particular, starvation of critical nutrients such as amino acids and glucose. That said, the relative contribution of these inputs is ambiguous, and many starvation medias are poorly defined or devoid of multiple nutrients. Here, we set out to create a quantitative dataset of autophagy across multiple stages in single, living cells, measured under normal growth conditions and during nutrient starvation of amino acids or glucose. We found that autophagy is induced by starvation of amino acids, but not glucose, in U2OS cells, and that MTORC1-mediated ULK1 regulation and autophagy are tightly linked to amino acid levels. While autophagy is engaged immediately during amino acid starvation, a heightened response occurs during a period marked by transcriptional upregulation of autophagy genes during sustained starvation. Finally, we demonstrated that cells immediately return to their initial, low-autophagy state when nutrients are restored, highlighting the dynamic relationship between autophagy and environmental conditions.

Introduction

Macroautophagy/autophagy is a highly conserved pathway that recycles cytoplasmic contents via a vesicular trafficking pathway that culminates in the lysosome. Under normal conditions, autophagy serves a housekeeping function in cells by degrading long-lived proteins and clearing damaged organelles. However, during stress, autophagy is activated to liberate internal nutrient pools to support metabolism and circumvent cell death. There is a growing appreciation for the role of this stress response pathway in cancer, where autophagy has been shown to promote the progression of KRAS and BRAF-driven tumors by supporting tumor-intrinsic cancer cell survival, and also, by regulating additional cell types in the tumor microenvironment (i.e., immune cells) [19].

The gatekeeper of autophagy is ULK1, a serine/threonine kinase that triggers the nucleation of an isolation membrane, or phagophore, the earliest autophagic membrane [1012]. The synthesis of this cup-shaped structure is largely promoted by the class III PI3K (PIK3C3) and its lipid product, phosphatidylinositol-3-phosphate (PI(3)P). PI(3)P decorates autophagic membranes and recruits effectors, such as double FYVE domain-containing protein 1 (DFCP1) and WD repeat domain phosphoinositide interacting protein 1 and 2 (WIPI1 and WIPI2) [1315]. VPS34 activity is required for the downstream activation of ATG9, a transmembrane protein that facilitates lipid transport to contribute to the expansion of the phagophore membrane [1620]. Maturation of the phagophore and eventual closure into a complete autophagosome is executed by two ubiquitin-like conjugation systems. The first system involves covalent binding of autophagy related protein 12 (ATG12), a ubiquitin-like protein, to autophagy related protein 5 (ATG5) and subsequent incorporation into a large oligomer with autophagy related protein 16 (ATG16) at the phagophore [21]. The second system involves the classic autophagosome-marker, microtubule associated protein 1 light chain 3 beta (MAP1LC3B; henceforth, LC3B) (Atg8 in yeast), which becomes covalently attached to phosphatidylethanolamine on autophagic membranes [22,23]. The location and enabling of LC3 conjugation to the vesicle is controlled by ATG12-5-16, which functions as an E3-like enzyme [24]. The completion of this process is marked by the autophagosome’s direct fusion with a lysosome (generating an autolysosome), or with an endosome destined for the lysosome (generating an amphisome), and the degradation of sequestered cargo.

Autophagy is tightly regulated by environmental conditions, most notably, it is activated by amino acid stress through regulation by mammalian target of rapamycin (MTOR; specifically MTOR complex 1 or MTORC1) (Fig 1A). Under amino acid sufficiency, activated MTORC1 restrains autophagy through inhibitory phosphorylation of the ULK1 complex (at Ser758) [1012,25,26]. This serves to limit autophagy-mediated catabolism during times of sufficient exogenous nutrient supply. Upon amino acid withdrawal, MTORC1 is repressed, thereby relieving its inhibition of ULK1 and activating autophagy.

Fig 1. Amino acid starvation, but not glucose starvation, induces autophagy in U2OS cells.

Fig 1

(A) MTORC1 and AMPK activity is influenced by amino acids and glucose, respectively, and regulate ULK1 activity, which induces autophagy. (B-E) U2OS cells were treated with full media (FM), FM lacking glucose (-Glc), or FM lacking amino acids (-aa) for the indicated times and cell lysates analyzed by immunoblot for ACC, total and phosphorylated at S79 (B, D), and S6K1 phosphorylated at T389 and actin as a loading control (C, E). Immunoblots were quantified and signal normalized to total ACC (for D) or actin loading control (for E) plotted. Symbols represent mean of 3 independent experiments and bars are s.e.m. (F-I) Monoclonal U2OS cell lines expressing DFCP1 (F), WIPI2B (G), WIPI1 (H), or ATG5 (I) were treated with FM (blue), -Glc (green), or -aa media (red) for 6 hours and subjected to live-cell fluorescent imaging. GFP-puncta (objects) for each reporter were quantified from single cells. Trajectories include mean objects per cell (symbols); bars represent 95% CI. (J-K) GFP-LC3B objects were quantified from cells treated with FM, -aa, or -Glc in the presence of BafA1 (to prevent lysosome degradation) or a vehicle control in 2 hour increments (J). The number of GFP-LC3 puncta synthesized (solid symbols) and degraded (open symbols) from time 0 min was calculated and plotted. The dashed lines demarcate where individual datasets were collected and data stitched together. Trajectories include mean puncta per cell (symbols); bars represent standard deviation.

To date, the prevailing dogma has been that in addition to amino acid stress, autophagy can also be activated by energetic stress through regulation of the energy-sensing AMP-activated protein kinase (AMPK) (Fig 1A). In this model, during energetic stress (i.e., decreased cellular ATP/AMP ratio), AMPK is activated and inhibits MTORC1 by at least two mechanisms: the phosphorylation of TSC2, an upstream negative regulator of MTORC1, and phosphorylation of RAPTOR, a component of the MTORC1 complex [27,28]. This repression of MTORC1 should contribute to ULK1 activation and autophagy induction. In addition, it is known that AMPK also directly phosphorylates ULK1 at several sites [2931]. While this regulation of AMPK on ULK1 was long thought to be a positive input, that is, AMPK activation increases ULK1-dependent autophagy, this has been challenged in recent years [3236]. For example, glucose starvation has been found to trigger AMPK-mediated phosphorylation of ULK1 at Ser556, which though initially viewed as an activating event, has recently been shown to inhibit autophagic flux [3739]. Thus, there is now a growing appreciation that the relationship between AMPK and autophagy is complex and in fact, AMPK may contribute to both the activation or inhibition of autophagy depending on the severity or level of energetic stress [37,40].

A major source of inconsistency across autophagy studies stems from differences in the exact media formulations used. Starvation media are often poorly defined and can vary by amino acid and glucose content, the presence and type of fetal bovine serum (which, unless dialyzed, contains undefined amounts of nutrients, including amino acids and glucose), and other components (reviewed in [40]). In addition, the starvation duration can range dramatically, from minutes (short duration) to days (long duration), further complicating comparisons. Given that autophagy is a highly dynamic process and technically challenging to measure with precision, it is thus not surprising that these disparate experimental conditions yield conflicting conclusions.

To address these limitations and to provide clarity on how nutrient stress affects autophagy, we used a well-characterized cancer cell line, U2OS, and fluorescent sensors that mark distinct stages of the autophagy pathway. We monitored autophagy during defined amino acids or glucose starvation over the course of 6 hours, capturing measurements at 5–10 minute intervals to generate a high-resolution view of autophagic dynamics. For this, we formulated defined medias to precisely limit these nutrients in isolation while controlling all other media components. Using these medias, we found that withdrawal of amino acids, but not glucose, induced autophagy in U2OS cells. We confirmed that MTORC1 regulation of ULK1 and the magnitude of autophagy were tightly linked and correlated with amino acid availability. Moreover, we found that while autophagy was activated immediately in response to amino acid deprivation, further upregulation occurred several hours later, concomitant with transcriptional upregulation of autophagy machinery. Finally, we demonstrated that cells were primed to return to a low-autophagy state when nutrients were replenished. In addition to these well-supported conclusions, we provide single-cell data from living cells captured at high temporal resolution across multiple stages of autophagy as a resource for other researchers.

Results

Starvation of amino acids, but not glucose, induces robust autophagy in U2OS cells

To understand the relative contribution of the major physiologic inputs to autophagy, we measured multiple stages of the pathway in U2OS cells cultured in each of three defined medias (see S1 Table for full formulations): 1) custom full media (“FM”), which contains the concentrations of amino acids, growth factors, glucose, and vitamins found in RPMI-1640 supplemented with 10% dialyzed fetal bovine serum (FBS); 2) amino acid starvation media (“-aa”), which is FM without amino acids; and 3) glucose starvation media (“-Glc”), which is FM without glucose. First, we confirmed that -Glc media increased AMPK activity as measured by phosphorylation of the AMPK substrate, ACC, at Ser79, an effect that was immediate and maintained throughout the entire 6 hour period (Fig 1B, D). We also established that amino acid starvation inhibited MTORC1, as indicated by a complete loss of phosphorylation of its substrate, S6K1, at T389 within 30 minutes (Fig 1C, E). We also detected a decrease in pS6K1-T389 in glucose-free media (-Glc) relative to full media (FM), consistent with the known negative regulation of MTORC1 by AMPK through TSC2 and RAPTOR [27,28].

To determine the consequences of these medias on autophagy, we used a panel of monoclonally derived U2OS cell lines expressing EGFP-fusions of key autophagy machinery including DFCP1, WIPI1, WIPI2B, ATG5, and LC3B (Fig 1A). Cells were plated in FM and then switched to either FM, -aa, or -Glc before fluorescent live-cell imaging over 6 hours. We found that fed cells (cultured in FM) generally expressed few (2.1 + /- 1.4) DFCP1-positive puncta, which represent omegasomes, the crescent-shaped structure that supports the forming phagophore, and these were relatively stable through the 6 hour imaging period (Fig 1F, blue). Amino acid starvation (-aa) increased DFCP1-positive puncta, primarily after 3 hours of treatment, peaking at an average of 7.1 puncta per cell by 6 hours (Fig 1F, red). In contrast, glucose-free media (-Glc) failed to induce DFCP1 puncta formation (Fig 1F, green). WIPI2B-positive puncta were also lowly abundant and responded similarly to -aa, rising from 0.3 to 6.5 puncta per cell on average (>20-fold), most substantially in the final 3 hours of starvation, while failing to respond to -Glc as well (Fig 1G). The second PI(3)P effector we quantified, WIPI1, also responded exclusively to -aa; however, this marker showed an immediate increase in puncta, rising from approximately 5–40 puncta per cell in the first hour of -aa, followed by a slow and steady increase through the remainder of the starvation period (Fig 1H). Similar to WIPI1, the first hour of -aa triggered a doubling in the number of ATG5-positive puncta, although these structures were overall very rare (1–2 per cell) (Fig 1I).

As LC3B is known to be conjugated to the growing autophagic membrane and degraded in the lysosome along with cargo, measuring it requires a more complex experimental design. We adopted a straightforward kinetic experimental design to approximate both the synthesis and degradation of GFP-LC3B-positive autophagic vesicles (AVs), which we observe as GFP-positive puncta, in FM, -aa, and -Glc medias. Our calculations were based on the principle that the AVs in a cell reflect a dynamic pool continually influenced by the synthesis of new AVs and loss of existing AVs to lysosomal degradation. We distinguished synthesis and degradation by measuring AVs over time in both the presence and absence of bafilomycin A1 (BafA1),a proton pump inhibitor that prevents lysosomal degradation [41]. Because BafA1 prevents degradation, synthesized AVs are quantified as those that accumulate over time in the presence of BafA1. We then compare AV counts observed with and without BafA1 to approximate AV degradation (see Methods and Table S2). Because the duration of BafA1 treatment must be limited, we spiked in BafA1 for either the first, middle, or final two hours of the 6-hour treatment period and quantified LC3-positive vesicles (Fig 1J). Similar to the other markers, we found that -aa caused a significant increase in LC3-positive vesicle synthesis, an effect that was apparent immediately and grew more robust over time (Fig 1K). In contrast, not only did glucose-free media not induce AV synthesis, glucose-free media actually suppressed it below the basal levels observed in FM (Fig 1K). For all conditions, the rate of AV synthesis and degradation was well-balanced (Fig 1K), underscoring the ability of these cells to regulate autophagy efficiently. Taken together, these data strongly suggest that autophagy is upregulated in U2OS cells in response to starvation of amino acids, but not glucose withdrawal.

To understand why glucose starvation failed to induce autophagy in our experiments, we compared the state of two major phosphorylation sites on ULK1, serine 758 (S758) and serine 556 (S556). First, we found that glucose starvation failed to reduce pULK1-S758, a critical inhibitory phosphorylation site on ULK1 regulated by MTORC1 [30], whereas this site was dephosphorylated by aa-starvation (S3A-B Fig). Second, we found that glucose starvation triggered and sustained high levels of pULK1-S556, which again was in contrast to a time-dependent dephosphorylation observed with aa-starvation (S3C Fig). Emerging evidence has found S556 to be an AMPK-mediated phosphorylation site, which is consistent with the increased AMPK activity we detected under glucose-free media conditions, and that it is associated with inhibition of ULK1 and autophagic flux, which is also consistent with our data [3840].

MTORC1-mediated autophagy is tuned to amino acid levels

After observing that amino acids are the dominant driver of autophagy in U2OS cells, we wanted to more precisely establish the relationship between amino acid levels and autophagy induction. For this, we titrated amino acids from 100% (the level of each amino acid in the RPMI-1640 formulation and our custom FM) down to 10%, 5%, and 0%, while keeping all other media components constant. At the end of the 6 hour treatment period, we saw that decreasing amino acids led to decreasing levels of pULK1-S758, with 0% aa causing a near complete loss of pULK1-S758, similar to that observed with pS6K1-T389 in Fig 1 (Fig 2A). These data were fit to a sigmoidal dose-response curve, which revealed an EC50 of 6.4% aa (+/- 1.2% aa) (Fig 2B). We then measured LC3-positive AV synthesis by supplementing BafA1 into these medias and imaging them between 4 and 6 hours of treatment. We found that reduction of amino acids in the media increased the rate of LC3 synthesis, with an EC50 of approximately 7.6% aa (+/- 2.5% aa) (Fig 2C-D). We confirmed that there was a linear negative relationship between pULK1-S758 and LC3 vesicle synthesis, consistent with relief of this phosphorylation site on ULK1 being a critical determinant of autophagy synthesis (Fig 2E). Moreover, this data suggests that amino acid levels must drop significantly from the amount in FM before there is an appreciable upregulation in autophagy.

Fig 2. ULK1 phosphorylation and autophagy levels are tightly associated and regulated by amino acid levels.

Fig 2

(A-B) U2OS cells were treated for 6 hours with FM (blue), indicated as 100% aa (the concentration found in RPMI-1640), or 10% (green), 5% (orange), or 0% (red) of that amino acid concentration. Cells were lysed and ULK1 phosphorylated at S758 quantified (relative to actin loading control and normalized to time 0 controls) (A). Bars represent means of 3 biological replicates. The data in (A) was fit to a sigmoidal dose-response curve (dashed line) to generate an EC50 of 6% aa (B). (C-D) Cells were treated with the medias described in A and imaged live from hours 4-6 in the presence of BafA1 (as in Fig 1K). GFP-LC3 puncta were quantified from cells and sum intensity plotted (this is the sum of the intensity of all GFP-positive pixels, an output used to avoid potential issues with aggregated vesicles). Trajectories include mean objects per cell (symbols); bars represent s.e.m.; black lines represent simple linear regression (C). The GFP-LC3 synthesis rates from the linear regression lines in (C) across amino acid concentrations were fit to a sigmoidal dose-response curve (dashed line) to generate an EC50 of 7% aa (D). (E) The rate of GFP-LC3 synthesis (derived from linear regression analysis, shown in (C) and the relative level of pULK1-S758 (from A) plotted to show a negative, linear association (dashed line, r2 = 0.815).

PI(3)P effectors are differentially regulated during starvation

Upon aa starvation, cells immediately increased the abundance of puncta marked by WIPI1, a PI(3)P effector, increasing nearly 8-fold within the first hour (Fig 3A). To determine whether these WIPI1-positive structures reflected newly synthesized PI(3)P-positive vesicles, we quantified puncta positive for EGFP-2xFYVE, a universal marker of PI(3)P-positive membranes in cells. We found that 2xFYVE-positive puncta were abundant in cells prior to starvation, with an average of 100 puncta per cell (Fig 3B). During the first hour of aa-starvation, this abundance did not change, although it increased modestly later in starvation (Fig 3B). This suggests that when cells are first aa-starved, cells respond by recruiting WIPI1 to pre-existing PI(3)P-positive membranes, potentially of endosomal origin as these are typically the most abundant EGFP-2xFYVE-positive structures [42]. In contrast to WIPI1, WIPI2B responded more slowly with robust increases in WIPI2B-positive puncta later in the aa starvation (Fig 3A). Specifically, it took 2–3 hours of aa starvation for 50% of the cell population to have at least 1 WIPI2B puncta (Fig 3C).

Fig 3. PI(3)Peffectors, WIPI1 and WIPI2B, show distinct responses to aa starvation.

Fig 3

(A) GFP-WIPI1 (green, left Y-axis) and GFP-WIPI2B (purple, right Y-axis) object counts over the 6 hour -aa treatment were overlaid. The gray region indicates the immediate starvation period (0-1 hours), and the yellow highlights the period of delayed autophagy under sustained starvation (3-6 hours). (B) EGFP-2xFYVE puncta (PI(3)P-positive cell membranes) were quantified from cells under FM (blue) or -aa (red) treatment. Note a lack of substantial puncta increase in the immediate (0-1 hour) period (gray shading). (C) The fraction of cells containing at least 1 GFP-WIPI2B puncta is plotted with time of -aa starvation. The dashed line represents 50% of the cell population. (D) Representative EGFP-2xFYVE puncta in U2OS cells treated with a VPS34 inhibitor (1 μM compound 31, lower panels) or vehicle control (upper panels). Blue = Hoechst nuclear stain; green = EGFP-2xFYVE; captured with a 60x oil objective. Scale bars in left panels are 20 μm and scale bars in right panels (insets) are 5 μm. (E) GFP-LC3 synthesis with BafA1 in the presence of compound 31 (1 μM) or vehicle control. BafA1 was added for 1 hour during either the first hour of -aa starvation (“0-1 hr” bars) or after 4 hours of -aa starvation (“4-5 hr” bars). Data shown represent GFP-LC3 puncta synthesis relative to vehicle control. Symbols represent mean and bars are s.e.m. **** = adjusted p < 0.0001, one-way ANOVA.

We next wanted to establish the requirement for PI(3)P both early and late in aa-starvation (when WIPI1 and WIPI2B respond most dramatically, respectively). For this, we treated cells with a small molecule inhibitor of VPS34 (compound 31), the lipid kinase that produces PI(3)P. Compound 31 significantly reduced PI(3)P, as evidenced by loss of EGFP-2xFYVE puncta (Fig 3D). Moreover, we observed an accompanying reduction in LC3-positive vesicle synthesis when measured both early (1 hour into aa-starvation) or late (5 hours into aa-starvation), consistent with these PI(3)P dynamics being critical for autophagy upstream of LC3 (Fig 3E).

Delayed autophagy is associated with transcriptional upregulation of machinery

We were intrigued by the observation that autophagy was particularly high late in starvation, beginning 3–4 hours into aa-deprivation, as evidenced by the increased abundance of nearly all markers measured (Fig 1). Though amino acids were removed from the extracellular media at time 0, we wondered if the intracellular level of amino acids might shed light on the magnitude of autophagy, in particular, those known to regulate autophagy, including leucine, arginine, methionine, asparagine, and glutamine [43]. To address this, we employed liquid chromatography mass spectrometry (LC-MS) to quantify amino acids from cells 0 min, 20 min, 1 hour, or 4 hours into aa-starvation. We found that there was nearly complete depletion of these amino acids within 60 minutes of aa-starvation (Fig 4A) and no significant change in any amino acid between the 1 hour and 4 hour timepoints that might explain a change in autophagy (Fig 4B).

Fig 4. Autophagy machinery is transcriptionally upregulated with sustained amino acid starvation.

Fig 4

(A) Intracellular amino acids were measured from triplicate samples after 0 min, 20 min, 1 hour, or 4 hours of -aa starvation using mass spectrometry. Levels shown relative to time 0 (non-starved cells). Boxes are 25th to 75th percentile; line in box is median; whiskers are 5th and 95th percentiles. Symbols are datapoints outside box and whiskers. Note, we detected 16 of the 20 amino acids provided in FM. (B) Intracellular amino acids known to regulate MTORC1 and autophagy are plotted individually. Bars are mean (relative to pool size at time 0) and s.e.m. from triplicate samples (individual replicates shown as symbols). (C) RNAseq profiling was performed from cells cultured during -aa starvation for the indicated times compared to FM treatments. Differentially expressed genes (log2 fold-change + /-1 -aa versus FM at 6 hours) are shown. (D) Expression of core autophagy genes (in counts per million, CPM) is shown at the indicated times of FM or -aa treatment.

Next, we reasoned that this timeframe may also be consistent with the induction of gene expression and transcription of autophagy genes [44,45]. To determine whether a transcriptional program might underlie this increase in autophagy, we harvested RNA from cells after 1, 2, 4, or 6 hours of aa-starvation or after the same duration of treatment with FM. We then analyzed transcript expression by RNAseq. Indeed, we found a significant transcriptional response to aa-starvation (Fig 4C) with 1,642 and 1,766 genes increased or decreased at least two-fold, respectively (S3 Table). Among the genes upregulated during aa-starvation, we identified enrichment of pathways consistent with a stress response, for example, the Reactome pathways “Response of EIF2AK1 (HRI) to heme deficiency” and “NGF-stimulated transcription”, which involve the integrated stress response and immediate early gene induction, respectively (S4 Table) [46,47]. Moreover, among the most significantly upregulated genes were ATF3, EGR1, and FOS, immediate early genes known to be induced as part of the amino acid response (AAR), a cytoprotective mechanism induced by amino acid withdrawal [48]. Importantly, autophagy genes (identified in the Human Autophagy Database [49]) were significantly enriched among those increased (two-sided p = 0.0009, Fisher’s exact test). Specifically, we observed an upregulation of genes encoding core autophagy proteins, including ULK1, ZFYVE1 (DFCP1), ATG12, MAP1LC3B (LC3B), GABARAPL1 (an LC3-like molecule), and SQSTM1 (p62, a selective autophagy cargo adaptor) (Fig 4D).

Nutrient replenishment immediately restores cells to their basal autophagy level

After characterizing the response of cells to aa withdrawal, we wondered how quickly they would respond to the replenishment of amino acids following starvation. To test this, we starved cells of aa for 6 hours and then restored amino acid levels fully and quantified DFCP1, WIPI1, WIPI2B, or LC3B for 1 hour (Fig 5A). We found that all cells responded remarkably quickly to aa replenishment, with restoration of the basal state within 15–20 minutes (Fig 5B-G). This swift response led us to wonder whether the disappearance of autophagic vesicles upon nutrient replenishment was from degradation in the lysosome or potentially another route of vesicle disassembly. To explore this, we quantified LC3-positive AVs during nutrient replenishment in the presence of BafA1, which as described earlier, prevents lysosomal degradation. If the vesicles that disappeared had done so through lysosomal degradation, we reasoned that their rapid decrease should be negated with BafA1 treatment. In fact, this is what we observed, instead seeing an increase in AV abundance with BafA1 in aa-starved cells replenished with FM (S2A Fig). To explore this further, we calculated the number of LC3-positive vesicles (puncta) synthesized and degraded during nutrient replenishment (using paired measurements with and without BafA1) and stitched it onto FM or aa-starvation data (from Fig 1K) (S5 Table). We determined that once FM was replenished to aa-starved cells, synthesis immediately slowed while degradation proceeded at a higher rate (S2B–C Fig). Within 30–60 minutes, synthesis and degradation were well-balanced and maintained at a rate (slope) very similar to the FM control cells (S2B Fig).

Fig 5. Autophagy levels are restored immediately upon amino acid replenishment.

Fig 5

(A) Cells were cultured with or without amino acids for 6 hours prior to a restimulation phase of 60 min with FM (containing amino acids). (B-C) Representative images of GFP-DFCP1 (B) or GFP-WIPI2B (C) puncta in U2OS cells that were starved of amino acids for 6 hours and subject to aa-restimulation for 0 min (left), 10 min (middle) or 20 min (right). Insets show 2x magnification of indicated region to highlight disappearance of puncta. (D-G) DFCP1 (D), WIPI2B (E), WIPI1 (F), and LC3B (G) quantified from cells during the restimulation period following -aa (red) or FM (blue) treatments. Symbols are mean GFP-positive puncta per cell and bars are s.e.m. Solid lines are non-linear regression models (one phase exponential decay). Gray shaded area emphasizes restoration to FM levels within 20 min of aa restimulation.

Taken together, this nutrient replenishment data suggests that cells are more buffered to the induction of autophagy in the face of starvation, showing a variable and often later autophagy induction, whereas they are primed to return to their basal homeostatic rate of autophagy the moment a stressor, in this case aa-starvation, is relieved.

Discussion

Here, we have provided a detailed and quantitative description of autophagy induced by amino acid deprivation in a widely used cancer cell line for signal transduction and autophagy research, including five protein phosphorylation sites and five fluorescent reporters for autophagy proteins. We supplemented these data with measurements of intracellular amino acids and mRNA transcript abundances. Collectively, we provide these data as a resource for the research community, for instance, to use in constructing or testing models or for exploring single cell behavior across a population. While we captured our data in a single cell line (U2OS), we expect our conclusions to have broad application to many cancer cell lines given the evolutionary conservation of the autophagy machinery and signaling networks involved.

Our most notable observation was that U2OS cells strongly induce autophagy in response to loss of amino acids, but fail to do so in response to glucose starvation. In fact, we found reduced LC3 vesicle dynamics during glucose starvation (see Fig 1K). While contradictory to the original dogma that glucose starvation activates AMPK to upregulate autophagy, our data is consistent with recent data that suggest a more complex relationship between AMPK and autophagy [34,36]. Specifically, it has been postulated that while autophagy may be induced by mild energetic stressors, it may be inhibited by severe stressors, such as complete glucose starvation (as used here), to avoid the energy expenditure required for autophagy and to conserve autophagy resources and protect critical cellular components [37,40,50,51]. Our data demonstrate that aa-starvation triggered robust dephosphorylation of ULK1 at two major inhibitory sites (S758 and S556), while phosphorylation of these sites remained high with glucose starvation. Thus, it is possible that differential phosphoregulation of ULK1, the critical gatekeeper to autophagy induction, underlies the drastically different responses to these two nutrient stressors in our study.

By using carefully defined medias, we established an EC50 of approximately 6–7% amino acids towards MTORC1-mediated ULK1 regulation (pULK1-S758) and autophagy vesicle synthesis during a 6 hour cell culture treatment. This demonstrates that the amino acid concentrations found in typical cell culture media (like RPMI-1640, the basis for our medias) are in far excess of a threshold that would induce autophagy, consistent with the original intent of these medias to support cell viability and proliferation for several days in culture [52].

While we draw conclusions from the population averages of data, we captured autophagy measurements from individual cells using live-cell imaging and analysis. Through this exercise, we uncovered significant cellular heterogeneity, despite each line being derived from a single clone. It is possible that the varied cellular responses we saw may relate to the cell cycle; for example, autophagy is inhibited during mitosis in order to protect nuclear contents during cell division [53]. Performing experiments in synchronized cells could address this possibility in future studies. In addition, it is possible that individual cell responses relate to individual gene and protein expression in single cells, which could be explored by cross-comparing autophagy responses with single-cell RNAseq. A limitation of our study was that all markers were studied separately in individual cell lines, so it would be informative to express multiple effectors in a single cell line and confirm whether conserved subpopulations of cells exist that display distinct autophagy responses. Finally, it is intriguing to consider that individual cells responding at the level of autophagy on distinct timescales and with varied magnitudes could be beneficial to a cell population as a whole. While autophagy serves as an important cytoprotective mechanism in response to stress, it can also be detrimental if engaged too robustly or for a prolonged period of time; therefore, a diversity of autophagic responses may be favorable to a growing tumor.

We highlighted a clear difference in the response of two closely related PI(3)P effectors, WIPI1 and WIPI2B, to autophagy induction in our cells. We postulate that WIPI1 is recruited immediately to abundant, pre-existing membrane structures, whereas WIPI2B is induced later and exhibits similar dynamics to DFCP1. Our data is consistent with WIPI2B localizing specifically to early autophagic membranes, and functioning closely with DFCP1 [14]. In contrast, WIPI1 has been found to localize to not only early autophagic membranes, but also plasma membrane, nuclear membrane, endoplasmic reticulum (ER), and LAMP1-positive membranes [54]. We found that WIPI1-positive structures were far more abundant than WIPI2B-positive structures and closer to the number of total 2xFYVE-positive puncta, which labels all PI(3)P-positive membrane compartments, including the endolysosomal pathway. Thus, our data would support a model whereby WIPI1 is exquisitely sensitive to autophagy induction but functions at sites of existing and abundant PI(3)P, perhaps endosomal in origin, in contrast to WIPI2B, which may be more specific to the omegasome and is engaged most significantly after sustained starvation.

We observed an apparent boost in autophagy several hours into amino acid starvation, which co-occurred with a transcriptional program involving a diverse collection of differentially expressed genes, including immediate early genes known to be induced as part of the amino acid response (AAR) [48]. In addition, of the 198 autophagy genes detected in our cells, 36 (18%) were upregulated compared with just 7 (4%) downregulated. This supports a model whereby cells faced with persistent starvation increase autophagy machinery to maintain a high level of autophagy.

After several hours of starvation, we found that cells responded swiftly and completely to the restoration of nutrients. In fact, all markers returned to basal levels within 10–20 minutes of amino acid replenishment, regardless of the initial level of autophagy in each cell. This illustrates that cells are primed to return to their basal state of low autophagy. In this respect, autophagy can be viewed as a robust response to stress but one that is carefully regulated to avoid detrimental consequences.

Methods

Mammalian cell culture, reagents, and antibodies

The human osteosarcoma cell line U2OS (HTB-96) was purchased from American Type Culture Collection, and cells maintained in RPMI-1640 medium (Gibco, 11-875-119) supplemented with 10% fetal bovine serum (Corning, 35–010-CV) and cultured at 37°C in a humidified atmosphere containing 5% CO2. Cells were seeded 48 hours before the start of assays. We generated monoclonal U2OS cell lines expressing the following fluorescent plasmids: 1) ptfLC3B was a gift from Tamotsu Yoshimori (Addgene plasmid #21074; http://n2t.net/addgene:21074; RRID:Addgene_21074) [55]; 2) pMXs-puro GFP-DFCP1 was a gift from Noboru Mizushima (Addgene plasmid #38269; http://n2t.net/addgene:38269; RRID:Addgene_38269) [56]; 3) pMXs-IP-EGFP-mATG5 was a gift from Noboru Mizushima (Addgene plasmid #38196; http://n2t.net/addgene:3819; RRID:Addgene_38196) [57]. We obtained two additional monoclonal U2OS cell lines (GFP-WIPI1-U2OS and GFP-WIPI2B-U2OS) as a kind gift from Tassula Proikas-Cezanne [58] and previously published U2OS-EGFP-2xFYVE [59]. Compound 31 (kind gift from Merck) and Bafilomycin A1 (BafA1; AG Scientific, B1183) stock solutions were prepared in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, D2650). Equal concentrations of DMSO was used for control treatments. Primary antibodies used were Total Acetyl-CoA Carboxylase (ACC; Cell Signaling Technology, 3662), Acetyl-CoA Carboxylase phospho-S79 (Cell Signaling Technology, 11818), S6K1 phospho-T389 (Cell Signaling Technology, 9205), ULK1 phospho-S758 (Cell Signaling Technology, 14202), ULK1 phospho-S556 (Cell Signaling Technology, 5869) and β-actin (Cell Signaling Technology, 3700). IRDye infrared fluorescent 680RD secondary goat anti-rabbit (926–68071) and anti-mouse (926–68070) purchased from LI-COR.

Defined medias

To prepare defined starvation medias, we reconstituted media containing the components of RPMI-1640, including the following reagents: 1XDPBS (Gibco, 14040−133), Phenol Red (Sigma-Aldrich, P3532), HEPES Buffer 1 M (Gibco, 15630−080), RPMI-1640 Vitamin Mix 100X (Sigma-Aldrich, R7256), RPMI-1640 Amino Acids Solution 50x (Sigma-Aldrich, R7131), sodium bicarbonate (Sigma-Aldrich, S5761), reduced Glutathione (Sigma-Aldrich, G6013), 200 mM Glutamine (Gibco, 25030−081), D-Glucose (Fisher Scientific, D16-500), and dialyzed Fetal Bovine Serum (Sigma-Aldrich, F0392). Amino acid starvation was prepared by adding all components except amino acid solution and glucose starvation media was prepared by adding all components except glucose. See S1 Table for full formulations. Medias were prepared, pH adjusted to 7.2–7.4, sterile-filtered, and stored at 4°C.

Immunoblot analysis

Cell lysates were prepared in ice-cold lysis buffer [40mM HEPES pH = 7.4, 1 mM ethylenediaminetetraaceticacid (EDTA), 120 mM sodium chloride, 50 mM bis-glycerophosphate, 1.0% Triton-X 100, 1.5 mM sodium orthovanadate, 50 mM sodium fluoride, and protease inhibitor cocktail (Sigma-Aldrich, P8340)]. Lysate samples were clarified by centrifugation for 10 min at 13,400 rpm and 4°C. Total protein concentration was determined using Protein Assay Dye Reagent Concentrate (Bio-Rad, 5000006). Proteins resolved by pre-cast 4–12% NuPage Bis-Tris Plus Midi gels (Invitrogen, WG1403BOX) or 3–8% NuPage Tris-Acetate Midi gels (Invitrogen, WG1603BOX) and electrotransferred onto either nitrocellulose or polyvinylidene difluoride membranes. Membranes blocked with StartingBlock (TBS) Blocking Buffer (Thermo, 37542) and primary antibodies diluted in StartingBlock T20 (TBS) Blocking Buffer (Thermo, 37543) at 4°C. After three 5 min 0.1% Tween20-TBS washes, membranes incubated in secondary antibodies StartingBlock T20 (TBS) Blocking Buffer for 1 hour at room temperature. Protein bands imaged using LI-COR Odyssey Infrared Imaging System and quantified with LI-COR Image Studio Software.

Fluorescence microscopy and vesicle quantification

Fluorescent cells (2.5 x 104 cells per chamber) were seeded in 4-chamber 35 mm CELLview dishes with glass bottom (Greiner Bio-One, 627870) and allowed to settle for 48 hours before imaging. Thirty hours post-seeding, media in each chamber was replaced with fresh RPMI-1640 with 10%FBS. Forty-eight hours later cells were washed with warmed 1X DPBS (Gibco, 14190144) and given indicated media. In Fig 3, 1 µM of Compound 31 or vehicle control (DMSO) was administered at the time media was changed with amino acid starvation. For imaging, media was supplemented with 100 nM bafilomycin A1 (BafA1; A.G. Scientific) or an equivalent amount of vehicle (DMSO) for U2OS-ptfLC3B cell lines only for 2 hours as depicted in Fig 1H. All other cell lines contained only relevant starvation medias. For restimulation experiments, after media change cells were cultured for 6 hours in their respective starvation media, at the end of 6 hours imaging was paused to change all media to complete nutrient media. After all conditions had complete media imaging was resumed imaging every position every 5 minutes for 55 minutes. Cells were imaged live by maintaining a humid environment at 37°C and 5% CO2 in an environmental chamber fixed around the microscope stage. Five fields of view per chamber were chosen and NIS Elements software (Nikon) set to automatically image each position every 10 min for 2 hours (U2OS-ptfLC3B) or every 20 min for 6 hours (DFCP1, WIPI1, WIPI2B, and ATG5) using perfect focus to maintain the desired focal plane. One image for each point was obtained before the media change and defined as time zero. For restimulation experiments, media was replaced with complete nutrient media after 6 hours of starvation and imaging continued every 5 minutes for 55 minutes. Fields of view were chosen for their inclusion of healthy cells which were adherent and at the periphery of a cluster. Cells were imaged using a 60X oil objective, in the FITC channel, on a Nikon Ti Eclipse fluorescent microscope. Images were segmented into individual cells by defining regions of interest (ROIs). All images were deconvolved, top-hat transformed (peak identification), and thresholded (intensity) using NIS Elements Software to quantify EGFP-LC3-positive, GFP-DFCP1-positive, GFP-WIPI1-positive, GFP-WIPI2B-positive, EGFP-ATG5-positive, or EGFP-2xFYVE-positive puncta per cell [60]. Processed, quality data was obtained from an average of 58 cells per marker per media condition. Single cell data are accessible online (https://doi.org/10.6084/m9.figshare.28797569).

LC3-positive AV synthesis and degradation calculations

GFP-LC3B-positive puncta represent LC3-positive autophagic vesicles (AVs). Cells contain a dynamic visible pool of AVs (that is, the number we quantify by fluorescent microscopy, described above) that is influenced by the addition of newly synthesized AVs and loss of degraded AVs as they fuse with the lysosomal compartment. Therefore, at a given timepoint, the number of AVs present in the cell is equal to the number of AVs that were present at an earlier timepoint plus the number of AVs that were synthesized between those two timepoints minus the number of AVs that were degraded (in the lysosome) between those two timepoints. This can be summarized by the following simple equation:

 𝐀𝐕t(𝐱+1)= 𝐀𝐕t(𝐱) + 𝐀𝐕(𝐬)  𝐀𝐕(𝐝)

Whereby

AVt(x) is the number of AVs quantified at time x

AVt(x+1) is the number of AVs quantified at time x + 1 (that is, later than x)

AV(s) is the number of AVs synthesized between time x and time x + 1

AV(d) is the number of AVs degraded in the lysosome between time x and time x + 1

The presence of BafA1 prevents lysosomal degradation and therefore, when quantifying AVs from BafA1-treated cells, we set AV(d) = 0. In this case, we can rearrange the equation to find that the number of AVs synthesized (AV(s)) equals the number of AVs at a given time minus the number of AVs that was present at time 0. To determine the number of degraded AVs, we use cells not treated with BafA1 (which allows undisturbed degradation) and quantify the number of AVs over time. We use these quantified AVs over time in the equation above along with the value calculated for AV(s) to solve for AV(d). The time of BafA1 exposure must be limited to avoid unintended effects and feedback mechanisms so we perform these LC3 measurements using 2-hour intervals with or without BafA1 and the desired media (FM, -aa, or -Glc). We calculate synthesis and degradation over time and display as the cumulative synthesis and degradation from the start of the first imaging period (t0), which is plotted in Fig 1K, and we use propagation of error rules to determine standard deviation after these calculations. Calculations can be found in S2 Table.

Amino acid measurements

180,000 U2OS cells were seeded per well of 6-well dishes in 2 ml RPMI-1640 + 10% FBS for 24 hours before being washed and incubated with -aa media for 20 min, 1 hour, or 4 hours (a time 0 control was also harvested for comparison of aa levels). Media was aspirated, cells rinsed twice with ice-cold 0.9% sodium chloride (Sigma S8776), dried completely, and snap-frozen on dry ice. To extract intracellular polar metabolites, 1.5 mL of extraction solvent (40% acetonitrile, 40% methanol, 40% water, v/v) was added to frozen plates, plates were scraped, and extracts collected in 1.5mL Eppendorf tubes. Extracts were incubated on ice for 1 hour, then centrifuged at 15000xg for 10 min. 850 µL of supernatant was collected, dried in a vacuum evaporator, and resuspended in 50uL of water for LCMS analysis. An additional aliquot of 50 µL from each supernatant was pooled, dried, and resuspended and analyzed between every six experimental replicates to monitor instrument and sample drift during analysis. Metabolomics was performed using anion-paired chromatography on an Agilent 1290 UHPLC coupled to an Agilent 6470 QQQ mass spectrometer operated in ESI- in dMRM mode as described previously [6164]. Peak picking and integration were conducted in MassHunter (v8.0, Agilent). Complete instrument parameters, compound transition list, and peak integration notes are available in S6 Table. Pool sizes of the indicated amino acids were normalized to the abundance in time 0 (non-starved) samples and plotted. All data was captured from 3 biological replicates per condition.

RNAseq

U2OS cells were plated on 6-well dishes at 180,000 cells per well in 2 ml full media (FM) and incubated at 37°C for 24 hours. The next day, the plating media was aspirated, washed, and replaced with either FM or amino acid-starvation media. Cells were incubated for 1, 2, 4, or 6 hours at 37°C before cells lysed and RNA harvested using Qiagen QIAShredders and RNeasy spin columns following manufacturer’s protocols. RNA was quantified using a Qubit fluorimeter and analyzed for integrity using a Bioanalyzer. Total RNA was subject to polyA enrichment and sequenced with 2x50 bp reads on an Illumina NovaSeq (30M raw reads per library). For analysis, quality trimming and adapter removal was performed using Trim Galore, reads were mapped to the human reference genome using STAR, and quality control of trimming and alignment performed with MultiQC. We generated gene counts using STAR and imported into R and analyzed with an internal RNA-seq analysis pipeline (Van Andel Research Institute Bioinformatics and Biostatistics Core).

Pathway enrichment analysis

Pathway enrichment analysis was performed using Metascape [65] for differentially expressed genes (DEGs) increased during aa-starvation as compared to full media (FM) by a log2-transformed fold-change (log2FC) ≥ 4. We searched for enrichment from a background gene list of 15,869 genes detected in our RNAseq experiment (15,862 recognized by Metascape). We searched all available pathways in Metascape (GO biological processes, Canonical pathways, Hallmark gene sets, Reactome gene sets, WikiPathways, BioCarta gene sets, KEGG pathways, PANTHER pathways). Significantly enriched pathways are identified in S4 Table for 4h and 6h aa-starvation. There were no genes increased by log2FC ≥ 4 at 1h or 2h aa-starvation. Pathways with a p-value < 0.01, a minimum count of 3 genes, and an enrichment factor > 1.5 (ratio between the genes present in the DEG list and the number of genes expected by chance) were grouped into clusters based on similarity (the most statistically significant term within a cluster is chosen to represent the cluster). p-values were calculated based on the cumulative hypergeometric distribution and q-values calculated using the Benjamini-Hochberg procedure to account for multiple testing.

Statistical analysis

All statistical tests performed in GraphPad Prism. Biological replicates and error bars represent standard error of the mean (SEM), unless otherwise indicated. Related to Fig 4, Fisher’s exact test was performed by building a contingency table with 36 autophagy database genes and 1,606 non-autophagy database genes increased ≥1 log2 FC by 6 hours in -aa versus FM, and 162 autophagy database genes and 14,065 non-autophagy database genes not increased (two-tailed T-test, p = 0.0009). For Fig 3, one-way ANOVA performed with Sidak’s multiple comparison test; vehicle versus compound 31 compared at each timepoint.

Supporting information

S1 Fig. Raw immunoblot images.

This file contains unmodified raw images of immunoblots included in this study.

(PDF)

pone.0340957.s001.pdf (11.8MB, pdf)
S2 Fig. ULK1 is differentially phosphorylated during amino acid and glucose starvation.

(A-C) U2OS cells were treated with full media (FM), aa-starvation media (-aa), or glucose-free media (-Glc) for the durations indicated before cells lysed and proteins analyzed by immunoblotting. A representative immunoblot is shown in (A). pULK1-S758 (relative to beta-actin) (B) or pULK1-S556 (relative to beta-actin) (C) were normalized to the first timepoint within each treatment and plotted with time (blue: FM; red: -aa; green: -Glc). Symbols are means of triplicate experiments and bars are s.e.m.

(TIF)

pone.0340957.s002.tif (11.7MB, tif)
S3 Fig. Amino acid replenishment slows LC3-vesicle synthesis.

(A) U2OS cells expressing GFP-LC3B were cultured for 6 hours in FM or -aa were then stimulated with fresh FM for 3 hours (green: -aa then FM; blue: FM then FM). Bafilomycin (BafA1) was supplemented (solid symbols) or not (open symbols) in the replenished FM and GFP-LC3 vesicles per cell were quantified with time. Symbols represent mean and bars represent s.e.m. Data shown at 10 minute intervals (all data available in Table S5). (B-C) GFP-LC3 puncta synthesized (closed symbols) or degraded (open symbols) was quantified during the FM replenishment period and stitched onto data showing hours 4–6 or FM vs -aa treatment (repurposed from Figure 1K). The dashed line indicates time of FM replenishment. The inset in (C) shows magnification of the boxed region in (B).

(EPS)

pone.0340957.s003.eps (1.8MB, eps)
S1 Table. Defined media formulations.

Formulation details for custom defined medias used in this study.

(XLSX)

pone.0340957.s004.xlsx (13.3KB, xlsx)
S2 Table. GFP-LC3 puncta synthesis and degradation in treatment with full media, aa-starvation, and glucose-starvation.

Average GFP-LC3 puncta per cell for cells treated with FM (tab1), amino acid starvation (tab 2), or glucose starvation (tab 3) with or without BafA1. Data captured in 2-hour intervals (1st, 2nd, 3rd datasets indicated). Synthesis and degradation quantified as described in Methods (and SD and SEM calculated using propagation of error rules). The cumulative (stitched) data from time 0 combines the synthesis and degradation values from all 3 datasets into one continuous plot.

(XLSX)

pone.0340957.s005.xlsx (78.6KB, xlsx)
S3 Table. RNAseq data from cells treated with full media and aa-starvation with time.

Values in C through J are log2-transformed counts per million (CPM); values in K are log2-transformed fold-change in -aa vs FM at 6 hours; in column M, an entry of “yes” indicates gene is described in the Human Autophagy Database (http://autophagy.lu/clustering/; accessed 11/29/2023).

(XLSX)

pone.0340957.s006.xlsx (2.2MB, xlsx)
S4 Table. Pathway enrichment analysis for genes increased during aa-starvation.

Pathways enriched among genes changing in expression during 6h (A) or 4h (B) aa-starvation. Count is number of genes from DEG input list present in the pathway; % is percentage of genes in the DEG list that are found in the pathway.

(XLSX)

pone.0340957.s007.xlsx (11KB, xlsx)
S5 Table. GFP-LC3 synthesis and degradation in cells replenished with full media following aa-starvation.

Average GFP-LC3 puncta per cell for cells treated with FM 6h and replenished with fresh FM for 120 min (columns A-O) or amino acid starved 6h then replenished with FM (columns Q-AE). Synthesis and degradation quantified as described in Methods (and SD and SEM calculated using propagation of error rules).

(XLSX)

pone.0340957.s008.xlsx (21.4KB, xlsx)
S6 Table. Mass-spectrometry technical file.

This file contains technical details relating to the amino acid measurements made by mass-spectrometry, including ion paired transition list (tab 1), ion paired MS parameters (tab 2), ion paired LC parameters (tab 3), and integration notes (tab 4).

(XLSX)

pone.0340957.s009.xlsx (122.7KB, xlsx)

Acknowledgments

We thank members of the MacKeigan laboratory for their critical discussions and feedback. We thank the Van Andel Institute Cores for providing mass spectrometry, genomics, and bioinformatics facilities and services. We also thank William Hlavacek, Yen Ting, and Song Feng of the Los Alamos National Laboratory for their critical discussions and support for this work.

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article, its supplementary materials, and openly available in figshare (doi: https://doi.org/10.6084/m9.figshare.28797569).

Funding Statement

This study was supported by grants and funding from the National Institutes of Health to J.P.M. (R01CA197398), and J.P.M. and R.G.J. (R01CA297993). J.P.M. funding from the National Cancer Institute (R21CA270588, R21CA252430, and R21CA263133) also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 2013;27(13):1447–61. doi: 10.1101/gad.219642.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Guo JY, Teng X, Laddha SV, Ma S, Van Nostrand SC, Yang Y, et al. Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev. 2016;30(15):1704–17. doi: 10.1101/gad.283416.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV, Khor S, et al. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 2014;4(8):914–27. doi: 10.1158/2159-8290.CD-14-0363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun. 2014;5:3056. doi: 10.1038/ncomms4056 [DOI] [PubMed] [Google Scholar]
  • 5.Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, et al. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013;3(11):1272–85. doi: 10.1158/2159-8290.CD-13-0397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.DeVorkin L, Pavey N, Carleton G, Comber A, Ho C, Lim J, et al. Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity. Cell Rep. 2019;27(2):502-513.e5. doi: 10.1016/j.celrep.2019.03.037 [DOI] [PubMed] [Google Scholar]
  • 7.Katheder NS, Khezri R, O’Farrell F, Schultz SW, Jain A, Rahman MM, et al. Microenvironmental autophagy promotes tumour growth. Nature. 2017;541(7637):417–20. doi: 10.1038/nature20815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581(7806):100–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yang A, Herter-Sprie G, Zhang H, Lin EY, Biancur D, Wang X, et al. Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. Cancer Discov. 2018;8(3):276–87. doi: 10.1158/2159-8290.CD-17-0952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ganley IG, Lam du H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009;284(18):12297–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–91. doi: 10.1091/mbc.e08-12-1248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jung CH, Jun CB, Ro S-H, Kim Y-M, Otto NM, Cao J, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003. doi: 10.1091/mbc.e08-12-1249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Axe EL, Walker SA, Manifava M, Chandra P, Roderick HL, Habermann A, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701. doi: 10.1083/jcb.200803137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Polson HEJ, de Lartigue J, Rigden DJ, Reedijk M, Urbé S, Clague MJ, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy. 2010;6(4):506–22. doi: 10.4161/auto.6.4.11863 [DOI] [PubMed] [Google Scholar]
  • 15.Proikas-Cezanne T, Ruckerbauer S, Stierhof Y-D, Berg C, Nordheim A. Human WIPI-1 puncta-formation: a novel assay to assess mammalian autophagy. FEBS Lett. 2007;581(18):3396–404. doi: 10.1016/j.febslet.2007.06.040 [DOI] [PubMed] [Google Scholar]
  • 16.Mailler E, Guardia CM, Bai X, Jarnik M, Williamson CD, Li Y, et al. The autophagy protein ATG9A enables lipid mobilization from lipid droplets. Nat Commun. 2021;12(1):6750. doi: 10.1038/s41467-021-26999-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Orsi A, Razi M, Dooley HC, Robinson D, Weston AE, Collinson LM, et al. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol Biol Cell. 2012;23(10):1860–73. doi: 10.1091/mbc.E11-09-0746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.van Vliet AR, Chiduza GN, Maslen SL, Pye VE, Joshi D, De Tito S, et al. ATG9A and ATG2A form a heteromeric complex essential for autophagosome formation. Mol Cell. 2022;82(22):4324-4339.e8. doi: 10.1016/j.molcel.2022.10.017 [DOI] [PubMed] [Google Scholar]
  • 19.Webber JL, Tooze SA. New insights into the function of Atg9. FEBS Lett. 2010;584(7):1319–26. doi: 10.1016/j.febslet.2010.01.020 [DOI] [PubMed] [Google Scholar]
  • 20.Young ARJ, Chan EYW, Hu XW, Köchl R, Crawshaw SG, High S, et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J Cell Sci. 2006;119(Pt 18):3888–900. doi: 10.1242/jcs.03172 [DOI] [PubMed] [Google Scholar]
  • 21.Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, et al. A protein conjugation system essential for autophagy. Nature. 1998;395(6700):395–8. doi: 10.1038/26506 [DOI] [PubMed] [Google Scholar]
  • 22.Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, et al. A ubiquitin-like system mediates protein lipidation. Nature. 2000;408(6811):488–92. doi: 10.1038/35044114 [DOI] [PubMed] [Google Scholar]
  • 23.Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720–8. doi: 10.1093/emboj/19.21.5720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell. 2008;19(5):2092–100. doi: 10.1091/mbc.e07-12-1257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chang Y-Y, Neufeld TP. An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation. Mol Biol Cell. 2009;20(7):2004–14. doi: 10.1091/mbc.e08-12-1250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Inoki K, Kim J, Guan K-L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52:381–400. doi: 10.1146/annurev-pharmtox-010611-134537 [DOI] [PubMed] [Google Scholar]
  • 27.Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–26. doi: 10.1016/j.molcel.2008.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Inoki K, Zhu T, Guan K-L. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577–90. doi: 10.1016/s0092-8674(03)00929-2 [DOI] [PubMed] [Google Scholar]
  • 29.Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456–61. doi: 10.1126/science.1196371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–41. doi: 10.1038/ncb2152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Karabiyik C, Vicinanza M, Son SM, Rubinsztein DC. Glucose starvation induces autophagy via ULK1-mediated activation of PIKfyve in an AMPK-dependent manner. Dev Cell. 2021;56(13):1961-1975.e5. doi: 10.1016/j.devcel.2021.05.010 [DOI] [PubMed] [Google Scholar]
  • 32.Cheong H, Lindsten T, Wu J, Lu C, Thompson CB. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A. 2011;108(27):11121–6. doi: 10.1073/pnas.1107969108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lang MJ, Martinez-Marquez JY, Prosser DC, Ganser LR, Buelto D, Wendland B, et al. Glucose starvation inhibits autophagy via vacuolar hydrolysis and induces plasma membrane internalization by down-regulating recycling. J Biol Chem. 2014;289(24):16736–47. doi: 10.1074/jbc.M113.525782 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Park J-M, Lee D-H, Kim D-H. Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun. 2023;14(1):2994. doi: 10.1038/s41467-023-38401-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ramírez-Peinado S, León-Annicchiarico CL, Galindo-Moreno J, Iurlaro R, Caro-Maldonado A, Prehn JHM, et al. Glucose-starved cells do not engage in prosurvival autophagy. J Biol Chem. 2013;288(42):30387–98. doi: 10.1074/jbc.M113.490581 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kazyken D, Dame SG, Wang C, Wadley M, Fingar DC. Unexpected roles for AMPK in the suppression of autophagy and the reactivation of MTORC1 signaling during prolonged amino acid deprivation. Autophagy. 2024;20(9):2017–40. doi: 10.1080/15548627.2024.2355074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mandic M, Misirkic Marjanovic M, Janjetovic K, Bosnjak M, Harhaji-Trajkovic L, Trajkovic V, et al. Multifaceted role of AMPK in autophagy: more than a simple trigger?. Am J Physiol Cell Physiol. 2025;329(5):C1380–97. doi: 10.1152/ajpcell.01058.2024 [DOI] [PubMed] [Google Scholar]
  • 38.Nwadike C, Williamson LE, Gallagher LE, Guan JL, Chan EYW. AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms. Molecular and Cellular Biology. 2018;38(10). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Barnaba C, Broadbent DG, Kaminsky EG, Perez GI, Schmidt JC. AMPK regulates phagophore-to-autophagosome maturation. J Cell Biol. 2024;223(8):e202309145. doi: 10.1083/jcb.202309145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kim D-H. Contrasting views on the role of AMPK in autophagy. Bioessays. 2024;46(3):e2300211. doi: 10.1002/bies.202300211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021;17(1):1–382. doi: 10.1080/15548627.2020.1797280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ, Gaullier JM, et al. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 2000;19(17):4577–88. doi: 10.1093/emboj/19.17.4577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Son SM, Park SJ, Stamatakou E, Vicinanza M, Menzies FM, Rubinsztein DC. Leucine regulates autophagy via acetylation of the mTORC1 component raptor. Nat Commun. 2020;11(1):3148. doi: 10.1038/s41467-020-16886-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bordi M, De Cegli R, Testa B, Nixon RA, Ballabio A, Cecconi F. A gene toolbox for monitoring autophagy transcription. Cell Death Dis. 2021;12(11):1044. doi: 10.1038/s41419-021-04121-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Lei Y, Klionsky DJ. Transcriptional regulation of autophagy and its implications in human disease. Cell Death Differ. 2023;30(6):1416–29. doi: 10.1038/s41418-023-01162-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11(3):619–33. doi: 10.1016/s1097-2765(03)00105-9 [DOI] [PubMed] [Google Scholar]
  • 47.Dijkmans TF, van Hooijdonk LWA, Schouten TG, Kamphorst JT, Fitzsimons CP, Vreugdenhil E. Identification of new Nerve Growth Factor-responsive immediate-early genes. Brain Res. 2009;1249:19–33. doi: 10.1016/j.brainres.2008.10.050 [DOI] [PubMed] [Google Scholar]
  • 48.Shan J, Lopez M-C, Baker HV, Kilberg MS. Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells. Physiol Genomics. 2010;41(3):315–27. doi: 10.1152/physiolgenomics.00217.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Human Autophagy Database (HADb). http://autophagy.lu/index.html 2023. 2023 November 30.
  • 50.Mandic M, Paunovic V, Vucicevic L, Kosic M, Mijatovic S, Trajkovic V, et al. No energy, no autophagy-Mechanisms and therapeutic implications of autophagic response energy requirements. J Cell Physiol. 2024;239(11):e31366. doi: 10.1002/jcp.31366 [DOI] [PubMed] [Google Scholar]
  • 51.Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Liu X, et al. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol. 2011;67(4):899–910. doi: 10.1007/s00280-010-1391-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Cantor JR. The Rise of Physiologic Media. Trends Cell Biol. 2019;29(11):854–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Odle RI, Walker SA, Oxley D, Kidger AM, Balmanno K, Gilley R, et al. An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis. Mol Cell. 2020;77(2):228-240.e7. doi: 10.1016/j.molcel.2019.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Proikas-Cezanne T, Robenek H. Freeze-fracture replica immunolabelling reveals human WIPI-1 and WIPI-2 as membrane proteins of autophagosomes. J Cell Mol Med. 2011;15(9):2007–10. doi: 10.1111/j.1582-4934.2011.01339.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3(5):452–60. doi: 10.4161/auto.4451 [DOI] [PubMed] [Google Scholar]
  • 56.Itakura E, Mizushima N. Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy. 2010;6(6):764–76. doi: 10.4161/auto.6.6.12709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Hara T, Takamura A, Kishi C, Iemura S-I, Natsume T, Guan J-L, et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol. 2008;181(3):497–510. doi: 10.1083/jcb.200712064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Bakula D, Müller AJ, Zuleger T, Takacs Z, Franz-Wachtel M, Thost A-K, et al. WIPI3 and WIPI4 β-propellers are scaffolds for LKB1-AMPK-TSC signalling circuits in the control of autophagy. Nat Commun. 2017;8:15637. doi: 10.1038/ncomms15637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Martin KR, Xu Y, Looyenga BD, Davis RJ, Wu C-L, Tremblay ML, et al. Identification of PTPsigma as an autophagic phosphatase. J Cell Sci. 2011;124(Pt 5):812–9. doi: 10.1242/jcs.080341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Martin KR, Barua D, Kauffman AL, Westrate LM, Posner RG, Hlavacek WS, et al. Computational model for autophagic vesicle dynamics in single cells. Autophagy. 2013;9(1):74–92. doi: 10.4161/auto.22532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kaymak I, Luda KM, Duimstra LR, Ma EH, Longo J, Dahabieh MS, et al. Carbon source availability drives nutrient utilization in CD8(+) T cells. Cell Metab. 2022;34(9):1298–311 e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ma EH, Verway MJ, Johnson RM, Roy DG, Steadman M, Hayes S, et al. Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells. Immunity. 2019;51(5):856-870.e5. doi: 10.1016/j.immuni.2019.09.003 [DOI] [PubMed] [Google Scholar]
  • 63.Madaj ZB, Dahabieh MS, Kamalumpundi V, Muhire B, Pettinga J, Siwicki RA, et al. Prior metabolite extraction fully preserves RNAseq quality and enables integrative multi-’omics analysis of the liver metabolic response to viral infection. RNA Biol. 2023;20(1):186–97. doi: 10.1080/15476286.2023.2204586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Schultz CR, Sheldon RD, Xie H, Demireva EY, Uhl KL, Agnew DW, et al. New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape. Biol Open. 2023;12(3):bio059647. doi: 10.1242/bio.059647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi: 10.1038/s41467-019-09234-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mohamed Abdelkarim

14 Aug 2025

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mohamed Abdelkarim

Academic Editor

PLOS ONE

Journal Requirements: 

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2.  PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.  

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

3. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories .

4.  Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: This study quantitatively measures autophagy components such as LC3, DFCP1, WIPI1, and WIPI2B under amino acid and glucose starvation using live-cell imaging in U2OS cells. The results demonstrate that autophagy is activated under amino acid starvation but not under glucose starvation. Furthermore, the study reveals transcriptional upregulation of autophagy-related genes that help sustain elevated autophagy levels over an extended period under amino acid starvation. The authors also show that reintroducing amino acids to starved cells restores autophagy to its basal state. However, major work is needed to clearly highlight the novelty of the study and how it addresses current gaps in knowledge.

Major comments:

Novelty and rationale of the study:

The current introduction would benefit from a more clearly articulated rationale that highlights both the specific limitations of prior studies and how this work would address them. While the interplay between glucose, amino acids, and autophagy has been extensively explored and recognized as context-dependent, the manuscript could better clarify the specific mechanistic insights it aims to contribute.

A potentially novel aspect of this study is its kinetic profiling of autophagy components, which can be utilized for modeling autophagy dynamics—an area less explored quantitatively. Refocusing the manuscript around this dataset and its relevance to predictive modeling could significantly strengthen its conceptual impact of the work.

The potential reasons for the lack of autophagy activation under glucose starvation remain unexplored. This could be studied by comparing the phosphorylation states of ULK1 at various sites during amino acid versus glucose starvation. Additionally, analyzing the effects of combined amino acid and glucose starvation may reveal important insights into the dynamics of mTORC1, AMPK, and ULK1 signaling.

Fig 1H-K experiment is well designed to calculate autophagy flux- please refer to these papers to calculate the autophagy flux for all three conditions. - . https://doi.org/10.1080/15548627.2022.2117515, 10.4161/15548627.2014.973338. This would assist the comparison of autophagy flux rates in more straightforward and interpretable manner.

As noted in the discussion, glucose deprivation appears to reduce autophagy flux—quantifying this would support the observation (See point previous point).

Consider pathway enrichment analysis of differentially expressed genes at various timepoints during amino acid starvation to better understand involved pathways.

Figures 2 and 5D–G use GFP sum intensity, while Figure 1 uses GFP puncta to assess autophagy activity—please clarify this discrepancy in measurement.

The authors raise an interesting point regarding the disassembly or degradation of autophagy vesicles following amino acid replenishment. This phenomenon could be further explored by monitoring autolysosomes or assessing LC3–LAMP1 colocalization under bafA1 treatment. This would provide novel insights into the change in autophagy flux and state of autophagy vesicles after replenishment.

Minor comments:

Please rework the abstract wording- “quantitative catalog” . Catalog suggests a comprehensive list of cell lines tested under different media conditions.

Use densitometry to quantify western blot results quantitatively.

Consider consolidating Figures 2A–2D into a single composite plot to facilitate direct comparison across conditions. Uniform axes and color-coding would enhance interpretability.

Clarification of Sigmoidal Fit (Figure 2B): The current legend refers to a sigmoidal dose-response fit yielding an EC50 of 6.4% aa (± 1.2% aa), but 2B depicts only the Relative pULK1-S758 value at 10% aa. Please address this and explicitly state the timepoint used for curve fitting in both the legend and the main text.

Include a scale bar in figure 3D.

Reviewer #2: 1. The manuscript reports that glucose starvation does not induce autophagy in U2OS cells, which contrasts with some existing literature. The authors should discuss potential reasons for this discrepancy.

2. The study notes significant cellular heterogeneity in autophagy responses, which is intriguing. But, the underlying causes are not explored. The authors could strengthen the discussion by proposing experiments or hypotheses to explain this variability.

3. The authors should discuss potential signaling pathways and cite relevant literature to contextualize their findings.

4. The use of BafA1 to measure LC3 accumulation is well-justified, but the manuscript could clarify whether the observed differences in LC3 puncta reflect changes in autophagosome synthesis, degradation, or both.

5. The study focuses on U2OS cells, but autophagy responses may vary across cell types. The authors should discuss whether their findings are likely to be generalizable or cell line-specific.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Korrapati Narasimhulu

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Feb 4;21(2):e0340957. doi: 10.1371/journal.pone.0340957.r002

Author response to Decision Letter 1


2 Dec 2025

Manuscript ID #PONE-D-25-35473

Response to Reviewers

We appreciate the time spent on this manuscript by our reviewers, as well as the constructive suggestions they have made to improve the significance and quality of our work. Answers to each comment presented by the reviewers are detailed below. We feel that the changes we have made in response to these comments strengthen the data that was presented before, and provide additional support for our conclusions.

Referee 1: The current introduction would benefit from a more clearly articulated rationale that highlights both the specific limitations of prior studies and how this work would address them. While the interplay between glucose, amino acids, and autophagy has been extensively explored and recognized as context-dependent, the manuscript could better clarify the specific mechanistic insights it aims to contribute. A potentially novel aspect of this study is its kinetic profiling of autophagy components, which can be utilized for modeling autophagy dynamics—an area less explored quantitatively. Refocusing the manuscript around this dataset and its relevance to predictive modeling could significantly strengthen its conceptual impact of the work.

We are grateful to the reviewer for this constructive feedback. We have expanded our Introduction to include more information on our rationale, including the evolving knowledge surrounding glucose, AMPK, and autophagy (see revised text on page 4 of Introduction) as well as the value of our data being captured with well-controlled media inputs and at high temporal resolution, addressing a limitation of prior studies that has contributed to ambiguity in this research area (see revised text on pages 5-6 of Introduction).

Referee 1: “The potential reasons for the lack of autophagy activation under glucose starvation remain unexplored. This could be studied by comparing the phosphorylation states of ULK1 at various sites during amino acid versus glucose starvation. Additionally, analyzing the effects of combined amino acid and glucose starvation may reveal important insights into the dynamics of mTORC1, AMPK, and ULK1 signaling.”

We appreciate this suggestion. To address this, we used immunoblotting to quantify two critical phosphorylation sites of ULK1, pSer758 and pSer556, in U2OS cells with FM, -aa, or -Glc from 15 minutes to 6 hours. We found that while aa-starvation triggered dephosphorylation of both sites, consistent with reported global dephosphorylation of ULK1 with aa-starvation, glucose starvation maintained high and sustained levels of both sites. The failure to relieve the inhibitory phosphorylation at Ser758 and high levels of pSer556, which has recently been found to associate with reduced ULK1 activity and autophagic flux, suggests that while glucose starvation indeed activates AMPK, the phosphorylation profile of ULK1 favors inhibition rather activation. This may relate to the fact that it has been reported that while mild energetic stress may activate AMPK to support autophagy, severe stress, such as the complete glucose starvation we tested, activates AMPK in such a way that it represses ULK1 and autophagy. These new data can be found in new Figure S1 and revised text on page 8-9 of Results.

Referee 1: “Fig 1H-K experiment is well designed to calculate autophagy flux- please refer to these papers to calculate the autophagy flux for all three conditions. - . https://doi.org/10.1080/15548627.2022.2117515, 10.4161/15548627.2014.973338. This would assist the comparison of autophagy flux rates in more straightforward and interpretable manner… As noted in the discussion, glucose deprivation appears to reduce autophagy flux—quantifying this would support the observation (See point previous point).”

Referee 2: “The use of BafA1 to measure LC3 accumulation is well-justified, but the manuscript could clarify whether the observed differences in LC3 puncta reflect changes in autophagosome synthesis, degradation, or both.”

We appreciate this constructive feedback from both reviewers and feel addressing it has now significantly improved our manuscript. We have now calculated LC3 synthesis and degradation as indicators of autophagy flux leveraging vesicle quantification from each media with and without BafA1 treatment, using a straightforward model similar to that described in Loos et al., 2014 (1). Please see revised Figure 1K, description in the text on page 8 of Results, and new section in Methods called “LC3-positive Synthesis and Degradation Calculations” on pages 20-21. Moreover, we provide the data as tables in new Table S2. Importantly, this allows us to firm demonstrate that autophagic vesicle synthesis (and concomitant degradation) are indeed suppressed by glucose starvation, while being significantly upregulated during aa-starvation.

Referee 1: “Consider pathway enrichment analysis of differentially expressed genes at various timepoints during amino acid starvation to better understand involved pathways.”

We performed pathway analysis using Metascape on genes increased by aa-starvation compared to full media (log2FC > 4) or). See text on pages 12-13 of Results and new Table S4. We identified pathways relating to stress responses, including “NGF-stimulated transcription” and “Response of EIF2AK1 (HRI) to heme deficiency” which involve the integrated stress response and immediate early gene induction, among upregulated genes during aa-starvation. This is consistent with our observation that many immediate early genes were increased along with autophagy machinery. It should be noted that we did not identify significant pathway enrichment among downregulated genes using this same approach so we did not include that analysis in the revised manuscript, instead focusing on the enrichment of pathways among upregulated genes.

Referee 1: “Figures 2 and 5D–G use GFP sum intensity, while Figure 1 uses GFP puncta to assess autophagy activity—please clarify this discrepancy in measurement.”

We appreciate the reviewer noting this discrepancy. At times, our lab has found that sum intensity, which is the sum of fluorescent intensity units of all pixels in puncta, is useful when measuring GFP-LC3-positive puncta because it can circumvent errors introduced when vesicle abundance is very high (e.g., with starvation plus BafA1). However, upon reevaluation of the data presented in this paper, we have determined that in most cases, we could display data as puncta (or vesicles) per cell in order to aid the interpretability of the results and make comparisons of the various markers clearer. Please find updated units in data presented in revised Figure 1K, revised Figure 5D-G, and new Figure S2. Despite this, we maintained the use of sum intensity units in Figure 2 because this figure focused on late stage aa-starvation (4-6 hours) and from cells treated with BafA1 where LC3 vesicles were most abundant. Moreover, we derived rates of LC3 vesicle synthesis in this figure by linear regression; therefore, it was imperative to use kinetic data in the linear range. We feel the data is most rigorous and interpretable within this Figure if the data is analyzed on a sum intensity scale. For your understanding, we provide two panels below comparing GFP-LC3 puncta per cell (left) and GFP-LC3 sum intensity per cell (right) at hours 4-6 of aa-starvation in the presence of BafA1 captured as part of the aa-titration data for Figure 2. Note that the abundance of puncta per cell approaches saturation at the final timepoints (plateaus) whereas the sum intensity of these puncta maintains linearity.

Referee 1: “The authors raise an interesting point regarding the disassembly or degradation of autophagy vesicles following amino acid replenishment. This phenomenon could be further explored by monitoring autolysosomes or assessing LC3–LAMP1 colocalization under bafA1 treatment. This would provide novel insights into the change in autophagy flux and state of autophagy vesicles after replenishment.”

Thank you for this feedback. To explore this, we quantified LC3 vesicle dynamics during the nutrient restimulation period in the presence and absence of BafA1. We reasoned that because BafA1 prevents lysosome degradation, if the vesicles that disappeared quickly in restimulation were doing so from lysosomal degradation, the decrease should be prevented with the addition of BafA1. Indeed, this is what we observed (see new Figure S2A). Moreover, we expanded our calculations of AV synthesis and degradation to include this restimulation dataset and observed that upon nutrient replenishment, vesicle synthesis seems to slow immediately to a rate similar to that of nutrient-replenished previously fed cells (see the slope of the solid red and solid blue symbols after 360 minutes in new Figure S2B). In contrast, AV lysosomal degradation continued early in the restimulation period at a rate similar to the previous rate during the aa-starvation before leveling out to balance with synthesis by about 30 minutes after restimulation (new Figure S2C). We have also provided these calculations in new Table S5. Please also refer to revised text on pages 13-14 of Results.

Referee 1: “Please rework the abstract wording- “quantitative catalog” . Catalog suggests a comprehensive list of cell lines tested under different media conditions.”

This was a helpful interpretation of the statement as originally written, which we have now updated to read more accurately “quantitative dataset” (see updated text on page 2 of the Abstract).

Referee 1: “Use densitometry to quantify western blot results quantitatively.”

We appreciate this suggestion. The immunoblots were captured using an Odyssey CLX machine and near-infrared fluorescence imaging, which are ideal for quantification. We quantified the pACC-S79 and pS6K1-T389 immunoblots displayed in Figure 1B and 1C – please see quantification in new Figure 1D and 1E). Moreover, we also quantified the newly generated immunoblots for ULK1-pS758 and ULK1-pS556, which we provide in new Figure S1B and S1C.

Referee 1: “Consider consolidating Figures 2A–2D into a single composite plot to facilitate direct comparison across conditions. Uniform axes and color-coding would enhance interpretability…Clarification of Sigmoidal Fit (Figure 2B): The current legend refers to a sigmoidal dose-response fit yielding an EC50 of 6.4% aa (± 1.2% aa), but 2B depicts only the Relative pULK1-S758 value at 10% aa. Please address this and explicitly state the timepoint used for curve fitting in both the legend and the main text.”

Thank you for your thorough review of Figure 2 and its legend. First, we have focused on the final period of starvation to improve clarity and interpretation of the data presented in this figure. Revised Figure 2A now displays the relative level of ULK1-pS758 after 6 hour treatment across the different aa concentrations in a single panel to aid the comparison. We have also matched the color-coding across all panels. The sigmoidal fits referred to in the text were inadvertently omitted from the version of Figure 2 uploaded originally; we sincerely appreciate this referee catching this in their thorough review. The sigmoidal curve and EC50 determinations were made for both pULK1-S758 and GFP-LC3 synthesis across the different aa concentrations, which are now included in revised Figure 2B and 2D. We used the pULK1-S758 quantification at 6 hours of treatment and the rate of GFP-LC3 synthesis from 4-6 hours (which is independently displayed in revised Figure 2C) and intended to highlight the similarity in influence of aa depletion of both of these markers of autophagy. We hope you find this newly revised Figure 2 and legend to be coherent and informative.

Referee 1: “Include a scale bar in figure 3D.”

Please see revised Figure 3D, which now includes scale bars in all panels. We also want to point out that Figure 3E is presented in a slightly different manner (a bar chart comparing an early and late point in aa-starvation, instead of a complete time series). We feel this display allows for the effects of compound 31 to be best represented (the original legend for Figure 3 was accurate for this bar chart).

Referee 2: ”The manuscript reports that glucose starvation does not induce autophagy in U2OS cells, which contrasts with some existing literature. The authors should discuss potential reasons for this discrepancy.”

The published literature concerning the role of AMPK and autophagy during energetic stress is indeed conflicting, with recent published commentaries discussing this at length, which we now cite (2, 3). We now explain and discuss this in more detail – please see revised text on pages 4-5 of the Introduction. Our new analysis of ULK1 phosphorylation demonstrates very different states between amino acid and glucose starvations, which may explain the failure to induce autophagy during glucose starvation in our experiments (please see new Figure S1). Moreover, it has been suggested that AMPK indeed activates autophagy during mild or moderate energetic stress but during a severe crisis, such as the complete deprivation of glucose we subjected our cells to, AMPK may actually inhibit autophagy in an effort to preserve the cell. We feel that by using precisely-formulated medias identical with the exception only of aa or glucose, quantifying markers that span multiple stages of autophagy, and capturing data with the comprehensive temporal resolution (from 5 minutes through 6 hours), our data is sound to be able to conclude with confidence that glucose starvation fails to induce autophagy under the reported conditions.

Referee 2: “The study notes significant cellular heterogeneity in autophagy responses, which is intriguing. But, the underlying causes are not explored. The authors could strengthen the discussion by proposing experiments or hypotheses to explain this variability.”

Thank you for this feedback. We have now added to the discussion of this observation – please see revised text on page 16 of the Discussion.

Referee 2: “The authors should discuss potential signaling pathways and cite relevant literature to contextualize their findings.”

Thank you for this feedback. We discuss the regulation of autophagy by MTOR and AMPK signaling pathways on page 4 of Introduction and a new pathway enrichment analysis in revised text on page 12-13 of Results.

Referee 2: “The study focuses on U2OS cells, but autophagy responses may vary across cell types. The authors should discuss whether their findings are likely to be generalizable or cell line-specific.”

We chose to complete our analyses in the U2OS cells, given evidence of robust autophagy and MTOR/AMPK signaling in this cell line. U2OS cells are a widely used and well-studied cell model for mTOR signaling. Research shows that the mTOR pathway is highly active in these cells and is a key driver of their growth and survival, and importantly, the autophagy pathway is highly responsive, dynamic, and intact. Because the autophagy pathway and the machinery explored are highly conserved, we expect our findings not to be cell line specific and could translate well to other cancer cell lines as well. We added a statement concerning this – see revised text on page 15 of the Discussion.

REFERENCES

1. Loos B, du Toit A, Hofmeyr JH. Defining and measuring autophagosome flux-concept and reality. Autophagy. 2014;10(11):2087-96.

2. Mandic M, Misirkic Marjanovic M, Janjetovic K, Bosnjak M, Harhaji-Trajkovic L, Trajkovic V, Vucicevic L. Multifaceted role of AMPK in autophagy: more than a simple trigger? Am J Physiol Cell Physiol. 2025;329(5):C1380-C97.

3. Kim DH. Contrasting views on the role of AMPK in autophagy. Bioessays. 2024;46(3):e2300211.

Attachment

Submitted filename: Response to Reviewers v112125.docx

pone.0340957.s011.docx (66.8KB, docx)

Decision Letter 1

Mohamed Abdelkarim

30 Dec 2025

Quantitative and Temporal Analysis of Autophagy: Differential Response to Amino Acid and Glucose Starvation

PONE-D-25-35473R1

Dear Dr. Jzffrey,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohamed Abdelkarim

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

**********

Reviewer #3: Neutral & clear

The authors have adequately addressed the reviewers’ comments, and the revised manuscript is satisfactory. I therefore recommend acceptance of the paper.

Slightly more formal (typical journal style)

The authors’ responses to the reviewers’ comments are appropriate and satisfactory. The revisions have improved the manuscript, and I recommend acceptance of the paper.

Formal & academic

The authors have responded appropriately to all comments raised during the review process. The revised version of the manuscript is satisfactory, and I recommend its acceptance for publication.

Very concise (editor-friendly)

The authors’ response is satisfactory. I recommend acceptance of the manuscript.

Positive and encouraging

The authors have carefully addressed all comments, and the revised manuscript meets the required standards. I recommend acceptance of the paper.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: Yes:  Mohamed Abdelkarim

**********

Acceptance letter

Mohamed Abdelkarim

PONE-D-25-35473R1

PLOS One

Dear Dr. MacKeigan,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mohamed Abdelkarim

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Raw immunoblot images.

    This file contains unmodified raw images of immunoblots included in this study.

    (PDF)

    pone.0340957.s001.pdf (11.8MB, pdf)
    S2 Fig. ULK1 is differentially phosphorylated during amino acid and glucose starvation.

    (A-C) U2OS cells were treated with full media (FM), aa-starvation media (-aa), or glucose-free media (-Glc) for the durations indicated before cells lysed and proteins analyzed by immunoblotting. A representative immunoblot is shown in (A). pULK1-S758 (relative to beta-actin) (B) or pULK1-S556 (relative to beta-actin) (C) were normalized to the first timepoint within each treatment and plotted with time (blue: FM; red: -aa; green: -Glc). Symbols are means of triplicate experiments and bars are s.e.m.

    (TIF)

    pone.0340957.s002.tif (11.7MB, tif)
    S3 Fig. Amino acid replenishment slows LC3-vesicle synthesis.

    (A) U2OS cells expressing GFP-LC3B were cultured for 6 hours in FM or -aa were then stimulated with fresh FM for 3 hours (green: -aa then FM; blue: FM then FM). Bafilomycin (BafA1) was supplemented (solid symbols) or not (open symbols) in the replenished FM and GFP-LC3 vesicles per cell were quantified with time. Symbols represent mean and bars represent s.e.m. Data shown at 10 minute intervals (all data available in Table S5). (B-C) GFP-LC3 puncta synthesized (closed symbols) or degraded (open symbols) was quantified during the FM replenishment period and stitched onto data showing hours 4–6 or FM vs -aa treatment (repurposed from Figure 1K). The dashed line indicates time of FM replenishment. The inset in (C) shows magnification of the boxed region in (B).

    (EPS)

    pone.0340957.s003.eps (1.8MB, eps)
    S1 Table. Defined media formulations.

    Formulation details for custom defined medias used in this study.

    (XLSX)

    pone.0340957.s004.xlsx (13.3KB, xlsx)
    S2 Table. GFP-LC3 puncta synthesis and degradation in treatment with full media, aa-starvation, and glucose-starvation.

    Average GFP-LC3 puncta per cell for cells treated with FM (tab1), amino acid starvation (tab 2), or glucose starvation (tab 3) with or without BafA1. Data captured in 2-hour intervals (1st, 2nd, 3rd datasets indicated). Synthesis and degradation quantified as described in Methods (and SD and SEM calculated using propagation of error rules). The cumulative (stitched) data from time 0 combines the synthesis and degradation values from all 3 datasets into one continuous plot.

    (XLSX)

    pone.0340957.s005.xlsx (78.6KB, xlsx)
    S3 Table. RNAseq data from cells treated with full media and aa-starvation with time.

    Values in C through J are log2-transformed counts per million (CPM); values in K are log2-transformed fold-change in -aa vs FM at 6 hours; in column M, an entry of “yes” indicates gene is described in the Human Autophagy Database (http://autophagy.lu/clustering/; accessed 11/29/2023).

    (XLSX)

    pone.0340957.s006.xlsx (2.2MB, xlsx)
    S4 Table. Pathway enrichment analysis for genes increased during aa-starvation.

    Pathways enriched among genes changing in expression during 6h (A) or 4h (B) aa-starvation. Count is number of genes from DEG input list present in the pathway; % is percentage of genes in the DEG list that are found in the pathway.

    (XLSX)

    pone.0340957.s007.xlsx (11KB, xlsx)
    S5 Table. GFP-LC3 synthesis and degradation in cells replenished with full media following aa-starvation.

    Average GFP-LC3 puncta per cell for cells treated with FM 6h and replenished with fresh FM for 120 min (columns A-O) or amino acid starved 6h then replenished with FM (columns Q-AE). Synthesis and degradation quantified as described in Methods (and SD and SEM calculated using propagation of error rules).

    (XLSX)

    pone.0340957.s008.xlsx (21.4KB, xlsx)
    S6 Table. Mass-spectrometry technical file.

    This file contains technical details relating to the amino acid measurements made by mass-spectrometry, including ion paired transition list (tab 1), ion paired MS parameters (tab 2), ion paired LC parameters (tab 3), and integration notes (tab 4).

    (XLSX)

    pone.0340957.s009.xlsx (122.7KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers v112125.docx

    pone.0340957.s011.docx (66.8KB, docx)

    Data Availability Statement

    The authors confirm that the data supporting the findings of this study are available within the article, its supplementary materials, and openly available in figshare (doi: https://doi.org/10.6084/m9.figshare.28797569).


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES